• Fisheries and Aquatic Sciences
• /
• 제26권3호
• /
• pp.181-187
• /
• 2023

The control of intestinal α-amylase and α-glucosidase is an effective therapeutic strategy for prevention of post-prandial hyperglycemia associated with diabetes mellitus. The objective of this study was to evaluate the anti-diabetes activities of Korean edible seaweed against α-amylase and α-glucosidase, two carbolytic enzymes involved in serum glucose regulation. Of the 41 species initially screened, Cladophora wrightiana var. minor, Eisenia bicyclis, Ecklonia cava, Ishige foliacea, and Ishige okamurae exhibited the strongest inhibitory activities from brown seaweeds. Asparagopsis taxiformis showed the strongest inhibitory effects from red seaweeds. The results of this study suggest that the crude brown seaweed extracts (C. wrightiana var. minor, E. bicyclis, E. cava, I. foliacea, and I. okamurae) and crude red seaweed extracts (A. taxiformis) may have beneficial effects suppressing the rise in postprandial hyperglycemia through the inhibition of α-amylase and α-glucosidase.

• Nutrition Research and Practice
• /
• 제18권2호
• /
• pp.165-179
• /
• 2024

BACKGROUND/OBJECTIVES: Mushroom consumption, rich in diverse nutrients and bioactive compounds, is suggested as a potential significant contributor to preventing cardiometabolic diseases (CMDs). This systematic review aimed to explore the association between mushrooms and cardiometabolic health outcomes, utilizing data from prospective cohort studies and clinical trials focusing on the general population, with mushrooms themselves as a major exposure. SUBJECTS/METHODS: All original articles, published in English until July 2023, were identified through searches on PubMed, Ovid-Embase, and google scholar. Of 1,328 studies, we finally selected 5 prospective cohort studies and 4 clinical trials. RESULTS: Existing research is limited, typically consisting of 1 to 2 studies for each CMD and cardiometabolic condition. Examination of articles revealed suggestive associations in some cardiometabolic conditions including blood glucose (both fasting and postprandial), high-density lipoprotein cholesterol related indices, high-sensitivity C-reactive protein, and obesity indices (body weight, body mass index, and waist circumference). However, mushroom consumption showed no association with the mortality and morbidity of cardiovascular diseases, stroke, and type 2 diabetes, although there was a potentially beneficial connection with all cause-mortality, hyperuricemia, and metabolic syndrome. CONCLUSION: Due to the scarcity of available studies, drawing definitive conclusions is premature. Further comprehensive investigations are needed to clarify the precise nature and extent of this relationship before making conclusive recommendations for the general population.

• Asian-Australasian Journal of Animal Sciences
• /
• 제25권10호
• /
• pp.1419-1429
• /
• 2012

A series of studies were carried out to investigate the supplemental effects of dietary garlic extracts (GE) on whole body amino acids, whole body and muscle free amino acids, fatty acid composition and blood plasma changes in 6 month old juvenile sterlet sturgeon (Acipenser ruthenus). In the first experiment, fish with an average body weight of 59.6 g were randomly allotted to each of 10 tanks (two groups of five replicates, 20 fish/tank) and fed diets with (0.5%) or without (control) GE respectively, at the level of 2% of fish body weight per day for 5 wks. Whole body amino acid composition between the GE and control groups were not different (p>0.05). Among free amino acids in muscle, L-glutamic acid, L-alanine, L-valine, L-leucine and L-phenylalanine were significantly (p<0.05) higher in GE than in control. However, total whole body free amino acids were significantly lower in GE than in control (p<0.05). GE group showed higher EPA (C22:6n3) and DHA (C22:5n3) in their whole body than the other group (p<0.05). In the second experiment, the effects of dietary garlic extracts on blood plasma changes were investigated using 6 month old juvenile sterlet sturgeon averaging 56.5 g. Fish were randomly allotted to each of 2 tanks (300 fish/tank) and fed diets with (0.5%) or without (control) GE respectively, at the rate of 2% of body weight per day for 23 d. At the end of the feeding trial, blood was taken from the tail vein (n = 5, per group) at 1, 12, and 24 h after feeding, respectively. Blood plasma glucose, insulin and the other serological characteristics were also measured to assess postprandial status of the fish. Plasma glucose concentrations (mg/dl) between two groups (GE vs control) were significantly (p< 0.05) different at 1 (50.8 vs 62.4) and 24 h (57.6 vs 73.6) after feeding, respectively, while no significant difference (p>0.05) were noticed at 12 h (74.6 vs 73.0). Plasma insulin concentrations (${\mu}IU$/ml) between the two groups were significantly (p<0.05) different at 1 (10.56 vs 5.06) and 24 h (32.56 vs 2.96) after feeding. The present results suggested that dietary garlic extracts could increase dietary glucose utilization through the insulin secretion, which result in improved fish body quality and feed utilization by juvenile sterlet sturgeon.

• Nutrition Research and Practice
• /
• 제1권2호
• /
• pp.100-104
• /
• 2007

Saururus chinensis Baill was reported to inhibit ${\alpha}-glucosidase$ in vitro and flatten postprandial increase in blood glucose in streptozotocin (STZ)-induced diabetic rats. We studied the effect of chronic consumption of S. chinensis Baill on blood glucose and lipid profile in STZ-induced diabetic male rats fed high fat diet. Male rats weighing 100-120 g were fed 30% fat diet with and without 10% freeze-dried leaves of S. chinensis Baill for 7 weeks after 1 week of adaptation. The rats were rendered diabetic by intravenous injection of STZ (60 mg/kg) after 6-week feeding of the assigned diets. At 1 week after the injection, the rats were sacrificed after an overnight fast. Plasma glucose ($380.2{\pm}14.4mg/dL$), total cholesterol ($93.9{\pm}7.9mg/dL$) and triglyceride levels ($123.6{\pm}7.5mg/dL$) of the S. chinensis Baill group were significantly lower than those of the control group ($418.1{\pm}12.0mg/dL,\;119.9{\pm}9.4mg/dL,\;152.0{\pm}10.3mg/dL$, respectively, p<0.05). Chronic consumption of S. chinesis Baill significantly decreased maltase activity of the small intestinal mucosa ($120.1{\pm}8.7U/g$) protein compared with the control group ($96.8{\pm}7.0U/g protein, p<0.05). These results suggest that S. chinensis Baill have hypoglycemic and hypolipidemic effects by inhibiting ${\alpha}-glucosidase$ activity in the animal model of diabetes mellitus.

• Food Science and Biotechnology
• /
• 제15권3호
• /
• pp.413-417
• /
• 2006

The purpose of this study was to investigate the hypoglycemic effect of Saururus chinensis Baill in vitro and in vivo. Methanol extract of S. chinensis Baill inhibited yeast ${\alpha}$-glucosidase activity by 49.8%, which was twice as strong as that of acarbose at a concentration of 0.5 mg/mL in vitro. The effect of S. chinensis Baill methanol extract on the postprandial increase in blood glucose levels was studied in streptozotocin-induced diabetic rats using a carbohydrate load test. Oral administration of S. chinensis Baill extract (500 mg/kg) significantly decreased incremental blood glucose levels at 60 and 90 min (p<0.05) after oral ingestion of starch (1 g/kg). The area under the glucose response curve of the S. chinensis Baill group was significantly decreased compared to that of the control group (p<0.05). The effect of prolonged feeding of S. chinensis Baill was studied in an animal model of type 2 diabetes. Three-week-old db/db mice were fed an AIN-93G diet or a diet containing 0.5% S. chinensis Baill extract for 7 weeks after 1 week of adaptation. Plasma glucose, insulin, and blood glycated hemoglobin levels of the mice fed S. chinensis Baill extract were significantly lower than those of the control group (p<0.05). Therefore, we conclude that S. chinensis Baill is effective in controlling hyperglycemia in animal models of diabetes mellitus.

• 대한한방내과학회지
• /
• 제43권3호
• /
• pp.363-374
• /
• 2022

Objective: This study was conducted to evaluate the hypoglycemic effect and safety of herbal extracts in patients with type 2 diabetes mellitus. Methods: We investigated 19 hospitalized patients with type 2 diabetes mellitus who were administered Banhasasim-tang (BST), Gumiganghwal-tang (GGT), or Pyeongwee-san (PWS) at Kyung Hee University Korean Medical Hospital for at least three days between January 2012 and December 2021. Their clinical characteristics and laboratory tests were reviewed retrospectively. The glucose-lowering effect of the herbal extracts was assessed by comparing blood glucose levels, including fasting blood sugar (FBS), two-hour postprandial glucose (PP2) levels, and glycated hemoglobin levels. To evaluate the safety of the herbal extract, liver function test and kidney function test results were compared, including aspartate aminotransferase (AST), alanine aminotransferase (ALT), blood urea nitrogen (BUN), and creatinine (Cr). Results: After taking herbal extracts, PP2 and HbA1c levels significantly decreased from 205.82 mg/dL to 171.41 mg/dL and 7.58% to 6.62%, respectively. The safety profile reported no significant difference after taking herbal extracts. Conclusions: BST, GGT, and PWS may have hypoglycemic effects in patients with type 2 diabetes mellitus taking hypoglycemic medication.

• 대한한방내과학회지
• /
• 제44권4호
• /
• pp.661-674
• /
• 2023

Abstract: This retrospective study delved into the effects and safety considerations associated with the concomitant usage of hypoglycemic agents and herbal extracts, specifically Pyeongwi-san (PWS) or HyangsaPyongwi-san (HSPWS) in the context of type 2 diabetes mellitus management. Methods: The investigation involved 38 inpatients with type 2 diabetes mellitus who received PWS or HSPWS treatment at Kyung Hee University Korean Medical Hospital from January 2012 to December 2022. By investigating clinical attributes and conducting laboratory assessments, this study aimed to discern the impact of these herbal extracts on blood glucose levels, encompassing fasting blood sugar (FBS) and mean 2-hour postprandial glucose (PP2) levels. Furthermore, the safety profile of the herbal extracts was assessed by comparing liver function indicators, including aspartate aminotransferase (AST), alanine aminotransferase (ALT), and γ-glutamyl transferase (GGT), alongside kidney function markers, such as blood urea nitrogen (BUN) and creatinine (Cr). Results: Following the administration of the herbal extracts, no statistically significant alterations in FBS and mean PP2 levels emerged compared to the baseline levels. Notably, the safety evaluation revealed no significant differences in liver and kidney function parameters following herbal extract administration. Conclusion: The results of this research indicate that using PWS or HSPWS alongside hypoglycemic medications could be a beneficial additional method for addressing digestive symptoms in individuals with type 2 diabetes mellitus. Notably, this combination seems to have no negative interactions with other drugs.

• 한국콘텐츠학회논문지
• /
• 제21권10호
• /
• pp.163-171
• /
• 2021

한국의 조리서와 한의서, 역사서 등 고문헌에는 건강과 음식, 치료에 관한 다양한 기록들이 있으며, 이러한 기록을 통해 '식치(食治)'의 원리를 발견할 수 있다. 식치(食治)는 '의료와 식품이 같은 원리로 작용한다' 라는 식약동원(食藥同源)의 뜻을 포함하는 의미로 전통지식으로만 그치지 않고 현대의 식문화까지 영향을 미치고 있다. 본 연구는 이러한 식치(食治)의 원리를 바탕으로 고문헌의 기록된 식품에 대한 과학적 검증을 통해 현대의 건강식품 소재로서 활용할 수 있는 토대를 마련하고자 하였다. 이를 위해 현대인의 대표적인 대사질환 중 하나인 혈당 조절과 관련이 있는 오미자, 콩, 꿀을 주원료로 하는 전통음료인 '오미갈수(五味渴水)'를 본 연구의 대상으로 선정하였다. 고문헌의 기록을 토대로 전통 오미갈수를 재현하였을 때 꿀에 의해 발생하는 음료의 엉김현상이나 섭취 후 혈당 상승 작용을 보완하기 위해 꿀을 대체할 수 있는 식품 소재를 발굴하였다. 이 소재를 활용하여 새롭게 제조한 오미갈수를 전통 오미갈수와 비교 시험을 통해 새롭게 제조한 오미갈수의 건강증진 및 품질개선 효과를 확인하였다. 본 연구를 바탕으로 전통지식의 하나인 식치의 원리를 활용한 과학적 연구를 통해 현대사회의 식품바이오, 헬스케어 등 의료 및 식품 분야의 다양한 콘텐츠로서 활용될 수 있는 기반을 마련하고자 한다.

• Journal of Nutrition and Health
• /
• 제56권1호
• /
• pp.24-34
• /
• 2023

상지 물추출물의 투여는 STZ 유도 당뇨 마우스의 공복 혈당, 혈중 총 CHO, LDL-CHO, 간 무게 및 간 조직 TG를 NC군 수준으로 감소시키고 혈장 총 CHO대비 HDL-CHO비는 NC군 수준으로 증가시켰으며, 소장 proximal region의 이당류 분해효소인 lactase, sucrase 활성을 억제하였다. 이는 상지를 차로 우려내어 음용할 경우 당뇨 예방 및 증상 개선의 가능성을 기대해 볼 수 있음을 제시한다. 상지는 국내산 뽕나무 부산물로 대량 생산될 뿐만 아니라 식품의 원료로 사용이 가능한 소재이므로 향후 상지 물추출물의 생리활성성분 분리 및 혈당조절기전 연구를 보다 깊이 수행한다면 안전하고 효과적인 고부가가치 혈당조절 기능성식품 개발의 기초자료로 활용될 수 있을 것이다.

• 한국식품영양과학회지
• /
• 제38권1호
• /
• pp.39-46
• /
• 2009

본 연구는 폐기되는 대두박으로부터 분리한 사포닌이 고 지방식이로 유도한 비만마우스의 체중, 지질 함량, 지질대사 및 내당능에 미치는 영향을 살펴보았다. 4주령의 C57BL/6 마우스(n=48)를 1주일간 적응시킨 후 정상식이를 급여한 정상군, 고지방을 급여한 고지방대조군, 고지방식이에 대두박 사포닌을 수준별(0.5%, 1.0%, 1.5%, w/w)로 급여한 군들과 양성대조물질인 가르시니아 캄보지아(1.0%, w/w)를 급여한 군으로 나누어 9주간 사육하였다. 체중증가량과 내장지방 (부고환 지방과 신장주변 지방) 무게는 고지방대조군에 비하여 대두박 사포닌 급여 수준에 의존적으로 낮아졌다. 캄보지아는 식이섭취량을 억제시킨 반면, 대두박 사포닌은 비만유도 마우스의 식이섭취량에 유의적인 영향을 미치지 않았다. 혈장 중의 렙틴 함량은 고지방대조군에 비하여 대두박사포닌 보충군에서 낮았다. 대두박 사포닌 급여수준에 관계 없이 혈장의 중성지질과 총 콜레스테롤 함량은 유의적으로 낮아진 반면, 사포닌 급여 수준에 의존적으로 변으로 중성지질 배설은 유의적으로 높았다. 한편, 캄보지아는 변의 지질 함량에 유의적인 영향을 미치지 않았다. 간조직 중의 중성지방과 콜레스테롤 함량 역시 고지방대조군에 비하여 대두박사포닌 급여군(1.5%)에서 유의적으로 개선되었으나 캄보아지군의 콜레스테롤 함량은 증가되었다. 고지방식이는 정상 식이에 비하여 혈당과 내당능을 유의적으로 증가시켰으나 대두박 사포닌과 캄보지아 급여는 혈당과 식후 혈당 변화를 효과적으로 개선하는 것으로 나타났다. 특히, 1.5% 대두박사포닌 급여군의 혈당은 정상군 수준이었다. 9주 동안 고지방식이 급여는 간조직 중의 지방산 합성과 산화효소활성을 모두 증가시켰는데 합성효소의 상승이 훨씬 큰 것으로 나타났다. 그러나 대두박 사포닌은 간조직 중의 지방산 합성과 산화효소활성을 정상화하였다. 이와 같이 대두박 사포닌은 비만유도 마우스에서 변으로의 중성지질 배설을 증가시키고 간조직에서 지질대사 관련 효소활성을 조절함으로써 체중조절과 혈당개선에 효과적이었다.